JMEDIC: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
JMEDIC
Largest movements
- Cash +€77,783
up €77,783 (+44.4%), from €175,260 to €253,042
mainly Net result for the year (+€114,039) and Depreciation (+€1,082)
- Current investments +€19,862
new in 2025: €19,862
- Receivables within one year +€15,785
up €15,785 (+36.1%), from €43,768 to €59,553
of which Other amounts receivable: +€16,520
- Reserves +€114,039
up €114,039 (+52.9%), from €215,753 to €329,792
- Financial income +€1,710
up €1,710 (+165.1%), from €1,036 to €2,746
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €229,807 | €342,930 | +€113,122 | +49.2% |
| Fixed assets | 21/28 | €4,073 | €3,904 | -€169 | -4.1% |
| Tangible fixed assets | 22/27 | €4,073 | €3,904 | -€169 | -4.1% |
| Furniture and vehicles | 24 | €2,931 | €2,884 | -€47 | -1.6% |
| Other tangible fixed assets | 26 | €1,142 | €1,020 | -€122 | -10.7% |
| Current assets | 29/58 | €225,734 | €339,026 | +€113,291 | +50.2% |
| Amounts receivable within one year | 40/41 | €43,768 | €59,553 | +€15,785 | +36.1% |
| Trade receivables | 40 | €735 | - | -€735 | |
| Other amounts receivable | 41 | €43,033 | €59,553 | +€16,520 | +38.4% |
| Current investments | 50/53 | - | €19,862 | +€19,862 | |
| Cash at bank and in hand | 54/58 | €175,260 | €253,042 | +€77,783 | +44.4% |
| Deferred charges and accrued income | 490/1 | €6,707 | €6,568 | -€139 | -2.1% |
| Total equity and liabilities | 10/49 | €229,807 | €342,930 | +€113,122 | +49.2% |
| Equity | 10/15 | €216,753 | €330,792 | +€114,039 | +52.6% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Reserves | 13 | €215,753 | €329,792 | +€114,039 | +52.9% |
| Distributable reserves | 133 | €215,753 | €329,792 | +€114,039 | +52.9% |
| Amounts payable | 17/49 | €13,054 | €12,138 | -€917 | -7.0% |
| Amounts payable within one year | 42/48 | €13,054 | €12,138 | -€917 | -7.0% |
| Trade debts | 44 | €1,746 | €734 | -€1,012 | -58.0% |
| Suppliers | 440/4 | €1,746 | €734 | -€1,012 | -58.0% |
| Taxes, remuneration and social security | 45 | €11,309 | €11,404 | +€95 | +0.8% |
| Taxes | 450/3 | €11,309 | €11,404 | +€95 | +0.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €947 | €1,082 | +€135 | +14.2% |
| Gross operating margin | 9900 | €161,404 | €161,524 | +€120 | +0.1% |
| Operating profit (loss) | 9901 | €160,457 | €160,442 | -€15 | 0.0% |
| Financial income | 75/76B | €1,036 | €2,746 | +€1,710 | +165.1% |
| Recurring financial income | 75 | €1,036 | €2,746 | +€1,710 | +165.1% |
| Financial charges | 65/66B | €870 | €766 | -€104 | -12.0% |
| Recurring financial charges | 65 | €870 | €766 | -€104 | -12.0% |
| Profit (loss) for the period before taxes | 9903 | €160,622 | €162,422 | +€1,799 | +1.1% |
| Income taxes | 67/77 | €47,537 | €48,382 | +€845 | +1.8% |
| Profit (loss) for the period | 9904 | €113,085 | €114,039 | +€954 | +0.8% |
| Profit (loss) for the period to be appropriated | 9905 | €113,085 | €114,039 | +€954 | +0.8% |
Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.